Frontiers in Immunology (Jan 2022)
Corrigendum: Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia
- Brwa Ali Hussein,
- Brwa Ali Hussein,
- Alexander Hallner,
- Alexander Hallner,
- Lovisa Wennström,
- Mats Brune,
- Anna Martner,
- Anna Martner,
- Kristoffer Hellstrand,
- Kristoffer Hellstrand,
- Elin Bernson,
- Elin Bernson,
- Fredrik B. Thorén,
- Fredrik B. Thorén
Affiliations
- Brwa Ali Hussein
- Tumor Immunology (TIMM) Laboratory at Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sweden
- Brwa Ali Hussein
- Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden
- Alexander Hallner
- Tumor Immunology (TIMM) Laboratory at Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sweden
- Alexander Hallner
- Department of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden
- Lovisa Wennström
- Department of Hematology, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
- Mats Brune
- Department of Hematology, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
- Anna Martner
- Tumor Immunology (TIMM) Laboratory at Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sweden
- Anna Martner
- Department of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden
- Kristoffer Hellstrand
- Tumor Immunology (TIMM) Laboratory at Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sweden
- Kristoffer Hellstrand
- Department of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden
- Elin Bernson
- Tumor Immunology (TIMM) Laboratory at Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sweden
- Elin Bernson
- Department of Obstetrics and Gynecology, Institute of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden
- Fredrik B. Thorén
- Tumor Immunology (TIMM) Laboratory at Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sweden
- Fredrik B. Thorén
- Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden
- DOI
- https://doi.org/10.3389/fimmu.2021.843461
- Journal volume & issue
-
Vol. 12
Abstract
No abstracts available.Keywords
- NK cell receptors
- gene variants
- single nucleotide polymorphism
- acute myeloid leukemia
- histamine/IL-2
- Re:Mission trial
